| Today's Open | $52.19 |
|---|---|
| Previous Close | $52.21 |
| Daily Range | $52.08 - $52.46 |
| 52-Week Range | $41.68 - $52.65 |
| Market Cap | $140.7B |
| P/E Ratio | 15.73 |
| Dividend (Yield) | $2.20 (4.5%) |
| Ex-Dividend Date Dividend Pay Date |
05/08/13 07/11/13 |
| Volume | 1,411,396 |
| Average Daily Volume | 3,224,031 |
| Current FY EPS | $3.64 |
Sector
Healthcare
Industry
Drugs
GlaxoSmithKline (GSK) Description
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/
News & Commentary
From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competiti
The 3 Deadliest Diseases in the U.S.
These deadly diseases kill more than 1 million Americans every year. But there's still some good news.
Clinical data and abstracts abound ahead of the American Society of Clinical Oncology's annual meeting.
3 Most Important Upcoming FDA Decisions of 2013
The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.Is AstraZeneca Gearing Up for a Shopping Spree?
With the company's pipeline in turmoil, AstraZeneca looks into the acquisition game.GSK's Top Competitors
(-0.17%)
(0.00%)
(-0.27%)
(1.21%)